Shandong Yidu Biotechnology Co., Ltd.

Primary objective: To evaluate the immunogenicity of freeze-dried human rabies vaccine (Vero cells) inoculated in healthy people with a 1-1-1-1 (simple four-dose) immunization schedule. Secondary objectives: (1) To evaluate the immune persistence of freeze-dried human rabies vaccine (Vero cells) inoculated in healthy people with a 1-1-1-1 (simple four-dose) immunization schedule; (2) To evaluate the safety of freeze-dried human rabies vaccine (Vero cells) inoculated in healthy people with a 1-1-1-1 (simple four-dose) immunization schedule.

Primary objective: (1) To evaluate the batch-to-batch consistency of immunogenicity of three consecutive production batches of freeze-dried human rabies vaccine (Vero cells) after administration with a five-dose (1-1-1-1-1) immunization schedule; Secondary objective: (1) To evaluate the safety of freeze-dried human rabies vaccine (Vero cells) administered in healthy people with a five-dose (1-1-1-1-1) immunization schedule.

To compare adherence to rabies vaccination with a four-dose schedule or a five-dose schedule of freeze-dried human rabies vaccine (Vero cells) in a retrospective manner.